Axogen, Inc. Common Stock (AXGN) is a publicly traded Healthcare sector company. As of November 8, 2026, AXGN trades at $49.52 with a market cap of $2.99B and a P/E ratio of -61.02. AXGN moved +2.34% today. Year to date, AXGN is +61.35%; over the trailing twelve months it is +108.50%. Its 52-week range spans $9.22 to $52.91. Analyst consensus is strong buy with an average price target of $58.00. Rallies surfaces AXGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for AXGN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $49.52 |
| Market Cap | $2.99B |
| P/E Ratio | -61.02 |
| EPS | $-0.67 |
| Dividend Yield | 1.00% |
| 52-Week High | $52.91 |
| 52-Week Low | $9.22 |
| Volume | 1.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $251.17M |
| Net Income | $-33.55M |
| Gross Margin | 74.56% |
11 analysts cover AXGN: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $58.00.